Pre-medication regimen showed an infusion-related reaction rate of 22.5 percent with intravenous RYBREVANT ®, a three-fold reduction from 67.4 percent historically seen with standard IRR management ...
Everyday Health on MSN
SCIg for primary immunodeficiency: Troubleshooting swelling, redness, and pain at the infusion site
Discover tips for managing swelling, redness, and pain at subcutaneous immunoglobulin (SCIg) infusion sites for primary ...
Reducing pembrolizumab infusions from 30 minutes to 10 minutes could be a safe alternative for patients and open hundreds of ...
Briumvi (ublituximab-xiiy) is a prescription drug used to treat certain types of multiple sclerosis (MS). Briumvi can cause side effects that range from mild to serious. Examples include upper ...
Although use of corticosteroid premedication prior to infliximab infusions is declining, it remains unnecessarily high despite limited benefit and the risk of serious adverse events from ...
Fabrazyme (agalsidase beta) is a brand-name intravenous (IV) infusion that’s prescribed for Fabry disease in adults and certain children. As with other drugs, Fabrazyme can cause side effects, such as ...
Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022 Based on our observations, it is ...
Truxima is a prescription drug used to treat certain blood cancers and rheumatoid arthritis. It can cause side effects ranging from mild (such as nausea and fatigue) to serious, including kidney ...
Avsola (infliximab-axxq) is a brand-name IV infusion that’s prescribed for certain autoimmune diseases, including rheumatoid arthritis, ulcerative colitis, and psoriasis. As with other drugs, Avsola ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results